Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
96.611,21
0,15%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Editas Medicine Inc (EDIT) Editas Medicine Inc (EDIT) Notizie

Editas Medicine Inc

EDIT
1,2505
-0,0495 (-3,81%)
08 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202515:03EDGAR2Form 8-K - Current report
13/1/202515:00GLOBEEditas Medicine Highlights New In Vivo Preclinical Proof of..
06/1/202515:00GLOBEEditas Medicine to Present at the 43rd Annual J.P. Morgan..
17/12/202422:17EDGAR2Form 8-K - Current report
12/12/202422:06EDGAR2Form 8-K - Current report
12/12/202422:00GLOBEEditas Medicine Announces Strategic Transition to in vivo..
09/12/202418:00GLOBEEditas Medicine Reports Updated Clinical Data from the RUBY..
05/12/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202415:00GLOBEEditas Medicine to Participate in Upcoming Investor..
04/11/202413:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202413:33EDGAR2Form 8-K - Current report
04/11/202413:30GLOBEEditas Medicine Announces Third Quarter 2024 Results and..
22/10/202413:04EDGAR2Form 8-K - Current report
22/10/202413:00GLOBEEditas Medicine Announces Progress Towards 2024 Goals,..
21/10/202422:30GLOBEEditas Medicine and Genevant Sciences to Collaborate to..
18/10/202422:01GLOBEEditas Medicine to Host Strategic Update Webinar to Detail..
04/10/202400:00GLOBEEditas Medicine Announces $50+ Million Monetization..
29/8/202422:19EDGAR2Form 144 - Report of proposed sale of securities
29/8/202422:17EDGAR2Form 144 - Report of proposed sale of securities
28/8/202415:00GLOBEEditas Medicine to Participate in Upcoming Investor..
07/8/202413:00GLOBEEditas Medicine Announces Second Quarter 2024 Results and..
31/7/202413:00GLOBEEditas Medicine Announces Second Quarter 2024 Results..
26/7/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202412:04EDGAR2Form 8-K - Current report
14/6/202409:01GLOBEEditas Medicine Reports New Safety and Efficacy Data from..
14/6/202409:00GLOBEEditas Medicine Announces New Safety and Efficacy Data from..
06/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202422:21EDGAR2Form 144 - Report of proposed sale of securities
31/5/202422:20EDGAR2Form 144 - Report of proposed sale of securities
31/5/202422:18EDGAR2Form 8-K - Current report
22/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202412:00GLOBEEditas Medicine Preclinical Data Highlights Advancement of..
08/5/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:29IHMARKETNEWSU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet..
08/5/202413:08EDGAR2Form 8-K - Current report
08/5/202413:00GLOBEEditas Medicine Announces First Quarter 2024 Results and..
02/5/202413:00GLOBEEditas Medicine Announces First Quarter 2024 Results..
01/5/202414:00GLOBEEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T..
22/4/202422:31GLOBEEditas Medicine to Present Pre-clinical Data Demonstrating..
06/3/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,30 Min: 1,24 Max: 1,32
Chiusura: 1,30

La tua Cronologia

NASDAQ
EDIT
Editas Medicine
AQSE
GLR.GB
Galileo Resources
BIT
UI681C
Unicredit Bank
USOTC
TOKCF
Tokyo Ohka Kogyo (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci